Aelix Therapeutics develops therapeutic vaccines and immunotherapies to treat HIV infection.
Aelix Therapeutics has raised $2.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2021.
Aelix Therapeutics's investors include Ysios Capital, EIT Health, Johnson & Johnson Robotics and Digital Solutions, CDTI, Criteria Venture Tech.
Aelix Therapeutics is headquartered in Barcelona, Spain.
Aelix Therapeutics develops therapeutic vaccines and immunotherapies to treat HIV infection.
Aelix Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aelix Therapeutics — Funding & Investors." VCBacked, September 16, 2021, https://www.vcbacked.co/company/aelix-therapeutics. Accessed September 30, 2026.
VCBacked. (2021). Aelix Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/aelix-therapeutics
{{cite web |title=Aelix Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aelix-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated